Pacific Edge Ltd
NZX:PEB

Watchlist Manager
Pacific Edge Ltd Logo
Pacific Edge Ltd
NZX:PEB
Watchlist
Price: 0.098 NZD 2.08% Market Closed
Market Cap: 79.6m NZD

P/FCFE
Price to FCFE

-3.2
Current
-4.3
Median
22.7
Industry
Higher than median
Lower than industry value

Price to Free Cash Flow To Equity (P/FCFE) ratio is a valuation multiple that compares a company’s market capitalization to the amount of free cash flow available for equity shareholders. This metric is very similar to the P/OCF but is considered a more exact measure, owing to the fact that it uses free cash flow, which subtracts capital expenditures (CapEx) from a company's operating cash flow.

P/FCFE
-3.2
=
Market Cap
79.6m NZD
/
FCFE
-25.3m NZD
Market Cap P/FCFE
NZ
Pacific Edge Ltd
NZX:PEB
79.6m NZD -3.2
FR
Pharnext SCA
OTC:PNEXF
6T USD -2 950 655.7
US
Abbvie Inc
NYSE:ABBV
339.4B USD 15.5
US
Amgen Inc
NASDAQ:AMGN
154.1B USD 48
US
Gilead Sciences Inc
NASDAQ:GILD
129.8B USD 11.7
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
129.4B USD -136.7
US
Epizyme Inc
F:EPE
94.1B EUR -465
AU
CSL Ltd
ASX:CSL
121.6B AUD 54.8
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
63.3B USD 18
US
Seagen Inc
F:SGT
39.3B EUR -63.9
NL
argenx SE
XBRU:ARGX
33.7B EUR -236.5
 
NZ
Pacific Edge Ltd
NZX:PEB
Average P/FCFE: 29.6
Negative Multiple: -3.2
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -2 950 655.7
US
Abbvie Inc
NYSE:ABBV
15.5
US
Amgen Inc
NASDAQ:AMGN
48
US
Gilead Sciences Inc
NASDAQ:GILD
11.7
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Negative Multiple: -136.7
US
E
Epizyme Inc
F:EPE
Negative Multiple: -465
AU
CSL Ltd
ASX:CSL
54.8
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
18
US
S
Seagen Inc
F:SGT
Negative Multiple: -63.9
NL
argenx SE
XBRU:ARGX
Negative Multiple: -236.5

P/FCFE Forward Multiples

Forward P/FCFE multiple is a version of the P/FCFE ratio that uses forecasted free cash flow to equity for the P/FCFE calculation. 1-Year, 2-Years, and 3-Years forwards use free cash flow to equity forecasts for 1, 2, and 3 years ahead, respectively.

1-Year Forward
P/FCFE
N/A
2-Years Forward
P/FCFE
N/A
3-Years Forward
P/FCFE
N/A